Process for making N-hydroxy3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]a mino] methyl]phenyl]-2E-2-propenamide and starting materials therefor

Details for Australian Patent Application No. 2007257883 (hide)

Owner Novartis AG

Inventors Parker, David John; Acemoglu, Murat; Bajwa, Joginder S.; Slade, Joel

Agent Davies Collison Cave

Pub. Number AU-B-2007257883

PCT Pub. Number WO2007/146718

Priority 60/804,527 12.06.06 US; 60/867,878 30.11.06 US

Filing date 7 June 2007

Wipo publication date 21 December 2007

Acceptance publication date 29 September 2011

International Classifications

C07D 209/16 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/146718 Priority application(s): WO2007/146718

29 September 2011 Application Accepted

  Published as AU-B-2007257883

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007257914-PAS Kinase regulates energy homeostasis

2007257882-Process for making salts of N-hydroxy3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]a mino]methyl]phenyl]-2E-2-propenamide